scispace - formally typeset
P

Peter G. Gibson

Researcher at University of Newcastle

Publications -  774
Citations -  53254

Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.

Papers
More filters
Journal ArticleDOI

Imaging for precision medicine: can V‐P SPECT measure mepolizumab response in asthma?

TL;DR: In this article, the authors report a case series describing treatment response to mepolizumab in four severe asthma patients, assessed by traditional methods and with objective ventilation/perfusion single photon emission computed tomography (V-P SPECT).
Journal ArticleDOI

Airway monocyte modulation relates to tumour necrosis factor dysregulation in neutrophilic asthma.

TL;DR: The results imply that increased sputum soluble TNF receptor levels observed in neutrophilic asthma relate to the increased recruitment of monocytes and neutrophils into the airways and their subsequent receptor shedding, and suggest an important contribution of airway monocytes to the altered inflammatory milieu in neutrophic asthma.
Journal ArticleDOI

The influence of asthma control on psychosocial outcomes for pregnant women with asthma

TL;DR: Pregnant women who are not able to get control of their asthma symptoms may experience worse quality of life and are likely to have more negative perceptions about their condition.
Journal ArticleDOI

Asthma in general practice: action plans or planned actions.

TL;DR: There's more than one way to implement effective asthma management in general practice and it's important to know which one is best for you and your patient.
Journal ArticleDOI

Targeted therapy for chronic respiratory disease: a new paradigm.

TL;DR: Targeted therapy has emerged as a highly effective treatment approach for chronic respiratory diseases and shows great results for the subgroup who respond and offers great promise as a future treatment direction.